Skip to main content

Table 4 Quality assessment of the included studies

From: The impact of ginsenosides on cognitive deficits in experimental animal studies of Alzheimer’s disease: a systematic review

Study quality:

Wang YC

Bombi Lee

Song XY

Quan QK

Zhao HH

Zhang X

Wang YL

Chu SH

Zhou LP

Wang XY

Wu W

ZangY

Research question specified and clear?

Outcome measures relevant for AD research

Are the characteristics of study population clear?

            

Species

Background/generation

Sex (and distribution)

N

N

N

Age

N

Presence and correct control group?

Where the groups similar at baseline (if not randomized think of weight and sex etc.)?

N

N

?

N

Is the experiment randomized?

N

N

Kind of supplement mentioned (ginsenoside)?

Age when supplementation started mentioned?

Duration of supplementation clear and specified?

Amount of ginsenoside mentioned

Administration route specified

Is the timing of the supplementation during the day specified and similar in both groups?

Methods used for outcome assessment the same in both groups?

Did report animals who died or were otherwise removed from the study

N

N

N

N

N

N

N

N

N

N

N

N

Blinded outcome assessment?

N

N

N

N

N

N

N

N

N

N

N

Was the outcome assessment randomized across the groups?

N

N

N

N

N

N

N

N

N

N

N

N

Total number of animals included in statistical analyses clear?

Age of sacrificing animals mentioned?

Quality score (items√)

17

19

18

18

18

15

18

15

18

17

18

18

  1. √ = fulfilling the criterion, no = not fulfilling the criterion, ? = not enough information to determine whether or not the raised criterion is